Training in Cancer Pharmacology

癌症药理学培训

• 批准号: 7681012
• 负责人: LEROY F LIU
• 金额: $ 12.94万
• 依托单位: UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-29 至 2011-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7681012
• 关键词: Training; cancer pharmacology

DESCRIPTION (provided by applicant): The Pharmacology Department at the Robert Wood Johnson Medical School (RWJMS) in collaboration with the faculty at the Ernest Mario School of Pharmacy at Rutgers University (EMSOP, RU) and the Cancer Institute of New Jersey (CINJ), are requesting funds to support a training program in cancer pharmacology for postdoctoral and predoctoral fellows. The collaborative program brings together faculty from the three participating institutions with a common interest in cancer pharmacology. The major strengths of the program include the top quality of the faculty, existing research collaborations between the faculty and the opportunity for the trainees for research in both basic as well as applied cancer pharmacology. Additionally, the trainees will be able to: a) serve as interns in the pharmaceutical industry that are located in the immediate vicinity of the campus around Piscataway and New Brunswick, NJ to become familiar with various aspects of pre clinical drug development and cancer pharmacology in the industrial setting and b) observe first hand the role cancer pharmacology plays in clinical oncology practice. The training grant will be a unique opportunity to attract talented candidates and train them to become future research scientists in cancer pharmacology. The predoctoral trainees will be enrolled in the Cellular and Molecular Pharmacology Graduate Program administered by the Pharmacology Department at RWJMS that involves both course work and laboratory research. Postdoctoral trainees, in addition to basic laboratory research in cancer pharmacology with one of the faculty, will be required to take two of the elective courses related to cancer and cancer pharmacology offered in the Department of Pharmacology. The faculty mentors of this training program from the three institutions have a broad range of research interests that span cell cycle control, basic mechanisms of tumorigenesis, understanding mechanisms of drug action and resistance, cancer gene therapy and non-invasive in vivo imaging, with a shared interest in cancer pharmacology

描述（由申请人提供）：罗伯特·伍德·约翰逊医学院 (RWJMS) 药理学系与罗格斯大学欧内斯特·马里奥药学院 (EMSOP, RU) 和新泽西州癌症研究所 (CINJ) 的教员合作，正在申请资金支持博士后和博士前研究员的癌症药理学培训计划。该合作项目汇集了来自三个参与机构对癌症药理学有共同兴趣的教师。该项目的主要优势包括高素质的教师队伍、教师之间现有的研究合作以及为学员提供基础和应用癌症药理学研究的机会。此外，学员将能够：a）在新泽西州皮斯卡塔韦和新不伦瑞克校园附近的制药行业担任实习生，熟悉临床前药物开发和癌症药理学的各个方面。工业环境和 b) 直接观察癌症药理学在临床肿瘤学实践中发挥的作用。培训补助金将是一个独特的机会，可以吸引有才华的候选人并培训他们成为未来的癌症药理学研究科学家。博士前培训生将参加由 RWJMS 药理学系管理的细胞和分子药理学研究生项目，该项目涉及课程作业和实验室研究。博士后学员除了与一名教员一起进行癌症药理学的基础实验室研究外，还需要选修药理学系提供的两门与癌症和癌症药理学相关的选修课程。来自三个机构的本次培训项目的导师具有广泛的研究兴趣，涵盖细胞周期控制、肿瘤发生的基本机制、药物作用和耐药机制的理解、癌症基因治疗和无创体内成像等，具有丰富的研究经验。对癌症药理学的共同兴趣

项目成果

The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells.

• DOI: 10.1016/j.yexcr.2008.07.028
• 发表时间: 2008-10-15
• 期刊: Experimental cell research
• 影响因子: 3.7
• 作者: Lin SY;Yang J;Everett AD;Clevenger CV;Koneru M;Mishra PJ;Kamen B;Banerjee D;Glod J
• 通讯作者: Glod J